
Medication Decisions
Upload your VCF file and instantly assess drug safety, dosage adjustments, and toxicity risks using CPIC-aligned pharmacogenomic analysis — tailored to your unique genetic profile.
Pharmacogenomic Risk Analyzer
Upload your VCF file and select medications to receive personalized risk predictions.
Upload VCF File
Variant Call Format v4.2
Drag & drop your VCF file here
or click to browse files
Select Drug(s)
Choose quick-select options or search below
How GenomeGuard Works
From raw genomic data to clinically actionable insights in seconds.
Upload VCF File
Drag & drop or browse your Variant Call Format (.vcf) file. We validate structure, check for required INFO tags (GENE, STAR, RS), and parse pharmacogenomic variants.
Select Drug(s)
Choose from supported drugs including Codeine, Warfarin, Clopidogrel, Simvastatin, Tacrolimus, and Isoniazid — or enter a custom drug name.
Get Analysis
It analyzes your variants across 20 critical pharmacogenes, predicts risk levels, and generates clinical explanations with specific variant citations.
Risk Classification
All in One Place
Drug–Gene Interactions
Key pharmacogenomic relationships analyzed by GenomeGuard
Prodrug → morphine conversion — Toxic if ultrarapid metabolizer
CODEINECYP2D6Clearance and target sensitivity — Bleeding if poor metabolizer/sensitive
WARFARINCYP2C9 + VKORC1Prodrug activation — Ineffective if poor metabolizer
CLOPIDOGRELCYP2C19Hepatic uptake — Myopathy if *5 variant
SIMVASTATINSLCO1B1Thiopurine inactivation — Myelosuppression if deficient
AZATHIOPRINETPMT + NUDT155-FU catabolism — Severe toxicity if DPYD deficient
FLUOROURACILDPYDImmunosuppressant clearance — Dose increase if expresser
TACROLIMUSCYP3A5Hepatic acetylation rate — Hepatotoxicity if slow acetylator
ISONIAZIDNAT2Severe cutaneous reactions — SJS/SCAR if *58:01 carrier
ALLOPURINOLHLA-BRed blood cell oxidative stress — Hemolysis if G6PD deficient
PRIMAQUINEG6PD
Red blood cell oxidative stress — Hemolysis if G6PD deficient
PRIMAQUINEG6PDSevere cutaneous reactions — SJS/SCAR if *58:01 carrier
ALLOPURINOLHLA-BHepatic acetylation rate — Hepatotoxicity if slow acetylator
ISONIAZIDNAT2Immunosuppressant clearance — Dose increase if expresser
TACROLIMUSCYP3A55-FU catabolism — Severe toxicity if DPYD deficient
FLUOROURACILDPYDThiopurine inactivation — Myelosuppression if deficient
AZATHIOPRINETPMT + NUDT15Hepatic uptake — Myopathy if *5 variant
SIMVASTATINSLCO1B1Prodrug activation — Ineffective if poor metabolizer
CLOPIDOGRELCYP2C19Clearance and target sensitivity — Bleeding if poor metabolizer/sensitive
WARFARINCYP2C9 + VKORC1Prodrug → morphine conversion — Toxic if ultrarapid metabolizer
CODEINECYP2D6
Genes & Drugs Covered
CYP2D6
Cytochrome P450 2D6
Metabolizes ~25% of all clinical drugs
Key Drugs
Common Variants
CYP2C19
Cytochrome P450 2C19
Key in prodrug activation and PPI clearance
Key Drugs
Common Variants
CYP2C9
Cytochrome P450 2C9
Metabolizes narrow therapeutic index drugs
Key Drugs
Common Variants
SLCO1B1
Solute Carrier Organic Anion Transporter 1B1
Mediates hepatic statin uptake
Key Drugs
Common Variants
TPMT
Thiopurine S-Methyltransferase
Clears thiopurines; prevents myelosuppression
Key Drugs
Common Variants
DPYD
Dihydropyrimidine Dehydrogenase
Rate-limiting step in fluoropyrimidine catabolism
Key Drugs
Common Variants
CYP3A5
Cytochrome P450 3A5
Tacrolimus dosing and clearance; key in transplant
Key Drugs
Common Variants
NAT2
N-Acetyltransferase 2
Isoniazid (anti-TB) acetylation rate & hepatotoxicity
Key Drugs
Common Variants
HLA-B
Human Leukocyte Antigen B
SJS/SCAR immune-mediated hypersensitivity
Key Drugs
Common Variants
G6PD
Glucose-6-Phosphate Dehydrogenase
Protects RBCs; deficiency causes drug-induced hemolysis
Key Drugs
Common Variants
VKORC1
Vitamin K Epoxide Reductase Complex 1
Target of warfarin; determines warfarin sensitivity
Key Drugs
Common Variants
UGT1A1
UDP-Glucuronosyltransferase 1A1
Irinotecan clearance; prevents severe diarrhea & neutropenia
Key Drugs
Common Variants
Start Your Pharmacogenomic Journey
Upload your VCF file and get your first analysis in under 30 seconds.
Bring Precision Medicine
to Your Institution
We're onboarding a limited number of hospitals and clinics for our early-access pilot. Get pharmacogenomic analysis integrated directly into your clinical workflow — ahead of general availability.
🔒 Your data is never shared. We comply with Indian health data regulations.